Skip to main content

Table 3 Antibiotic resistance in Gram-negative isolates

From: The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study

Antibiotics

Escherichia coli,% (n = 39)

Klebsiella pneumoniae, % (n = 9)

Pseudomonas aeruginosa, % (n = 6)

MDR bacteria, % (n = 37)

Amikacin

12.8

44.4

0

18.9

Ampicillin

100

100

33.3

100

Aztreonam

89.7

88.9

50

91.9

Ceftazidine

76.9

100

0

100

Ciprofloxacin

69.2

66.7

0

91.9

Ceftriaxone

100

100

33.3

100

Cefepime

82.1

100

0

100

Gentamicin

74.4

77.8

0

81.1

Imipenem

5.1

33.3

0

13.5

Levofloxacin

64.1

55.6

0

75.7

Ampicillin-Sulbactam

97.4

100

33.3

100

Compound Sulfamethoxazole

87.2

100

33.3

100

Piperacillin

15.4

0

0

16.2